✦ LIBER ✦

Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

✍ Scribed by Zhiwei Sui; Quanjiao Chen; Rui Wu; Hongbo Zhang; Mei Zheng; Hanzhong Wang; Ze Chen

Publisher: Springer Vienna
Year: 2010
Tongue: English
Weight: 317 KB
Volume: 155
Category: Article
ISSN: 1432-8798
DOI: 10.1007/s00705-010-0621-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Protection against influenza virus infec

Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant

✍ Hideki Hasegawa; Takeshi Ichinohe; Peter Strong; Izumi Watanabe; Satoshi Ito; Sh 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

## Abstract Chitin in the form of microparticles (chitin microparticles, CMP) has been demonstrated to be a potent stimulator of macrophages, promoting T‐helper‐1 (Th1) activation and cytokine response. In order to examine the mucosal adjuvant effect of CMP co‐administered with influenza hemaggluti

Protection against influenza virus infec

Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant

✍ Takeshi Ichinohe; Izumi Watanabe; Eriko Tao; Satoshi Ito; Akira Kawaguchi; Shin- 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 319 KB

A safe and effective adjuvant is necessary to enhance mucosal immune responses for the development of an inactivated intranasal influenza vaccine. The present study demonstrated the effectiveness of surf clam microparticles (SMP) derived from natural surf clams as an adjuvant for an intranasal influ

Induction of cross-protective immunity a

Induction of cross-protective immunity against influenza A virus H5N1 by an intranasal vaccine with extracts of mushroom mycelia

✍ Takeshi Ichinohe; Akira Ainai; Tomoyuki Nakamura; Yukihito Akiyama; Jun-ichi Mae 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 1 views

## Abstract The identification of a safe and effective adjuvant that is able to enhance mucosal immune responses is necessary for the development of an efficient inactivated intranasal influenza vaccine. The present study demonstrated the effectiveness of extracts of mycelia derived from edible mus